For the specific analysis of endothelial NO synthase (eNOS) function i
n the coronary vasculature, we generated a mouse homozygous for a defe
ctive eNOS gene (eNOS-/-). Western blot as well as immunohistochemical
staining revealed the absence of eNOS protein in eNOS-/-mice. Aortic
endothelial cells derived from eNOS-/-mice displayed only background l
evels of NOx formation compared with wild-type (WT) cells (88 versus 1
990 pmol NOx h(-1)/mg protein(-1)), eNOS-/-mice were hypertensive (mea
n arterial pressure, 135+/-15 versus 107+/-8 mm Hg in WT) without the
development of cardiac hypertrophy. Coronary hemodynamics, analyzed in
Langendorff-perfused hearts, showed no differences either in basal co
ronary flow or in maximal and repayment flow of reactive hyperemia. Ac
ute NOS inhibition with N-omega-nitro-L-arginine methyl ester (L-NAME)
in WT hearts substantially reduced basal flow and reactive hyperemia.
The coronary response to acetylcholine (ACh) (500 nmol/L) was biphasi
c: An initial vasoconstriction (now, -35%) in WT hearts was followed b
y sustained vasodilation (+190%). L-NAME significantly reduced vasodil
ation in WT hearts (+125%) but did not alter the initial vasoconstrict
ion. In eNOS-/-hearts, the initial vasoconstriction was augmented (-70
%), whereas the ACh-induced vasodilation was nor affected, Inhibition
of cyclooxygenase with diclofenac converted the ACh-induced vasodilati
on into vasoconstriction (-49% decrease of basal no iii). This effect
was even more pronounced in eNOS-/-hearts (-71%). Our results demonstr
ate that (1) acute inhibition of eNOS reveals a role for NO in setting
the basal coronary vascular tone as well as participation in reactive
hyperemia and the response to ACh; (2) chronic inhibition of NO forma
tion in eNOS-/-mutant mice induces no changes in basal coronary now an
d reactive hyperemia, suggesting the activation of important compensat
ory mechanisms; and (3) prostaglandins are the main mediators Of the A
Ch-induced vasodilation in both WT and eNOS-/-mice.